Vantage Consulting Group’s Accendra Health ACH Stock Holding History

Vantage Consulting Group’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-453	Closed	-$12K	–	1107
2020 Q4	$12K	Buy	+453	New	+$11.7K	﹤0.01%	1119

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vantage Consulting Group's ACH Position: Q1 2021 in Review

Vantage Consulting Group sold out of Accendra Health (ACH) in Q1 2021, closing a stake of 453 shares — an estimated $12K sold.

Vantage Consulting Group first reported a position in ACH in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 253 funds tracked by Wall St. Rank hold ACH as of Q1 2021.

Vantage Consulting Group reported no remaining Accendra Health position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 453 Accendra Health shares in Q1 2021, an estimated $12K.
Vantage Consulting Group first reported a position in Accendra Health in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Accendra Health position peaked at $12K in Q4 2020.
253 funds tracked by Wall St. Rank held Accendra Health as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.